Community-Scale Surveillance of SARS-CoV-2 and Influenza A Viruses in Wild Mammals, United States, 2022–2023
Sampling of mammal communities across the United States during 2022-2023 detected evidence of SARS-CoV-2 antibodies in 3 new species and 2 previously described species and evidence of influenza A antibodies in 2 previously described species. Our analysis provides surveillance and sampling guidance for detection of rare exposure events.
Authors
- Steven I. Rekant (ORCID: https://orcid.org/0000-0002-7358-1091)
- Grete Wilson‐Henjum (ORCID: https://orcid.org/0000-0002-2284-8745)
- Ryan S. Miller (ORCID: https://orcid.org/0000-0003-3892-0251)
- J.B. Heale
- Kim M. Pepin (ORCID: https://orcid.org/0000-0002-9931-8312)
- José D. Flores (ORCID: https://orcid.org/0000-0003-1622-7800)
- Kyle Van Why (ORCID: https://orcid.org/0000-0001-9234-3542)
- Jane Hewitt
- R.G. Dyer
- J. Jeffrey Root (ORCID: https://orcid.org/0000-0003-4177-1824)
- Derek Collins
- Diego G. Diel (ORCID: https://orcid.org/0000-0003-3237-8940)
- Ian H. Plummer
- Creighton Wellman
- Johannes H.W. de Wilt (ORCID: https://orcid.org/0000-0001-6773-9668)
- David L. Bergman (ORCID: https://orcid.org/0000-0002-6757-643X)
- Jeffrey C. Chandler (ORCID: https://orcid.org/0000-0002-3318-135X)
- Holly White (ORCID: https://orcid.org/0000-0002-8028-4271)
- Jesse Morris
- Alex Worgo
- John Paul Seman
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-07-24
- DOI
- https://doi.org/10.3201/eid3108.241671
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35